Inspec

Inspec P/B

The P/B (Price-to-Book Ratio) of Inspec (6656.T) as of Oct 21, 2026 is 2.37. In the previous year, P/B (Price-to-Book Ratio) was 2.56 — a change of -7.57% (lower).

P/B

2.37

YoY

-7.57%

Last updated:

P/B (Price-to-Book Ratio) of Inspec is 2026 2.37 . P/B (Price-to-Book Ratio) of Inspec was 2025 2.56 . It decreases by -7.57% lower compared to the previous year.

The Inspec P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2019
1.98 JPY
Jan 1, 2020
1.20 JPY
Jan 1, 2021
2.72 JPY
Jan 1, 2022
2.26 JPY
Jan 1, 2023
1.74 JPY
Jan 1, 2024
2.28 JPY
Jan 1, 2025
2.56 JPY
Jan 1, 2026
2.37 JPY
The Inspec P/B history
YEARP/BYoY
2.37-7.57%
2.56+12.58%
2.28+30.42%
1.74-22.72%
2.26-16.86%
2.72+126.80%
1.20-39.67%
1.98-21.50%
2.53-12.54%
2.89-24.92%
3.85-5.70%
4.08-17.74%
4.96—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

P/B (Price-to-Book Ratio) of Inspec is 2.37 in 2026.

P/B (Price-to-Book Ratio) of Inspec changed from 2.56 to 2.37, representing a -7.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Inspec since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Inspec with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Inspec

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Inspec